Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage (Q35840033)

10 August 2017

1 reference

title

Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage (English)

1 reference

cerebral amyloid angiopathy

10 August 2017

1 reference

1 reference

Mark O McCarron

1

1 reference

10 August 2017

James A R Nicoll

series ordinal

2

1 reference

10 August 2017

publication date

1 August 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

3

1 reference

10 August 2017

issue

8

1 reference

10 August 2017

page(s)

484-492

1 reference

Intracranial hemorrhage following thrombolytic therapy for acute myocardial infarction

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Older age and elevated blood pressure are risk factors for intracerebral hemorrhage after thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Dutch, Flemish, Italian, and Arctic mutations of APP and resistance of Abeta to physiologically relevant proteolytic degradation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Hereditary cerebral haemorrhage with amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Cerebral hemorrhage from amyloid angiopathy and coronary thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Cerebral amyloid angiopathy: prospects for clinical diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Prevalence of cerebral vascular amyloid-beta deposition and stroke in an aging Australian population: a postmortem study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Cerebral amyloid angiopathy in aged Chinese: a clinico-neuropathological study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Cerebral amyloid angiopathy in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Cerebral amyloid angiopathy in the aged

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Autopsy study of incidence and distribution of cerebral amyloid angiopathy in Hisayama, Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Clinical manifestations of cerebral amyloid angiopathy-related inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Reversible leukoencephalopathy associated with cerebral amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Intracerebral haemorrhage and cerebral amyloid angiopathy: CT features with pathological correlation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Apolipoprotein E ϵ4 and cerebral hemorrhage associated with amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Progression of cerebral amyloid angiopathy: accumulation of amyloid-beta40 in affected vessels

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Amyloid β-protein length and cerebral amyloid angiopathy-related haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Lack of an association between apolipoprotein E epsilon 4 and cerebral amyloid angiopathy in elderly Japanese

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

APOE and cerebral amyloid angiopathy in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid beta from the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Cerebrovascular disease is a major factor in the failure of elimination of Abeta from the aging human brain: implications for therapy of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease. Pro-CAA position statement.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Computer-assisted three-dimensional image analysis of cerebral amyloid angiopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Miliary aneurysms and "fibrinoid" degeneration of cerebral blood vessels

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Cerebral hemorrhage produced by ruptured dissecting aneurysm in miliary aneurysm

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 22-1996. Cerebral hemorrhage in a 69-year-old woman receiving warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Petechial hemorrhages accompanying lobar hemorrhage: detection by gradient-echo MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

MRI detection of new hemorrhages: potential marker of progression in cerebral amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Cerebral amyloid angiopathy-related hemorrhage. Interaction of APOE epsilon2 with putative clinical risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

High frequency of apolipoprotein E ?2 Allele in hemorrhage due to cerebral amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Fatal hemorrhage during anticoagulation of cardioembolic infarction: role of cerebral amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Individual risk assessment for intracranial haemorrhage during thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Intracranial hemorrhage associated with thrombolytic therapy for elderly patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Comparative efficacy of thrombolytics in acute myocardial infarction: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Tissue plasminogen activator for acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Unriddling the role of matrix metalloproteinases in human cerebral stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: Experience from the GUSTO-I Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Surgical risk of hemorrhage in cerebral amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Postoperative outcome of 37 patients with lobar intracerebral hemorrhage related to cerebral amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Surgical intervention, biopsy and APOE genotype in cerebral amyloid angiopathy-related haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Surgery for primary intracerebral hemorrhage: is it safe and effective? A systematic review of case series and randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

MRI evidence of past cerebral microbleeds in a healthy elderly population

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Cerebral microbleeds as a risk factor for subsequent intracerebral hemorrhages among patients with acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Asymptomatic microbleeds as a risk factor for aspirin-associated intracerebral hemorrhages

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Cerebral microbleeds are regionally associated with intracerebral hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Silent intracerebral microhemorrhages in patients with ischemic stroke. Amsterdam Vascular Medicine Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Silent cerebral microbleeds on T2*-weighted MRI: correlation with stroke subtype, stroke recurrence, and leukoaraiosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Neuropathologic correlates of leuko-araiosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Thrombolysis for ischemic stroke in patients with old microbleeds on pretreatment MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Labeling of cerebral amyloid in vivo with a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Neuroimaging of vessel amyloid in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Intracranial hemorrhage after use of tissue plasminogen activator for coronary thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Intracerebral hemorrhage related to cerebral amyloid angiopathy and t-PA treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Intracerebral hemorrhage after fibrinolytic therapy for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Decline in autopsies for deaths attributed to cerebrovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Lobar hemorrhages. Where do they come from? How do they get there?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Thrombolysis induces cerebral hemorrhage in a mouse model of cerebral amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Cerebral amyloid angiopathy. A critical review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Apolipoprotein E genotype, coagulation, and survival following acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Depressed platelet status in an elderly patient with hemorrhagic stroke after thrombolysis for acute myocardial infarction. GUSTO-III Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Leukoencephalopathy in diffuse hemorrhagic cerebral amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Amyloid beta-protein induces the cerebrovascular cellular pathology of Alzheimer's disease and related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Pathogenic effects of D23N Iowa mutant amyloid beta -protein

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Amyloid-beta-induced degeneration of human brain pericytes is dependent on the apolipoprotein E genotype.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Protease nexin-2/amyloid beta protein precursor. A tight-binding inhibitor of coagulation factor IXa.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Fibrillar amyloid beta-protein binds protease nexin-2/amyloid beta-protein precursor: stimulation of its inhibition of coagulation factor XIa.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Protease nexin-2/Amyloid beta-protein precursor regulates factor VIIa and the factor VIIa-tissue factor complex

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Localization of a fibrillar amyloid beta-protein binding domain on its precursor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Immunohistochemical characterization of cerebrovascular amyloid in 46 autopsied cases using antibodies to beta protein and cystatin C.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Characterization of amyloid fibril protein from a case of cerebral amyloid angiopathy showing immunohistochemical reactivity for both beta protein and cystatin C.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Abeta does not induce oxidative stress in human cerebrovascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

beta-Amyloid-mediated vasoactivity and vascular endothelial damage.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Pathogenic A beta induces the expression and activation of matrix metalloproteinase-2 in human cerebrovascular smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Matrix metalloproteinase-9 and spontaneous hemorrhage in an animal model of cerebral amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Amyloid β-Protein Stimulates the Expression of Urokinase-type Plasminogen Activator (uPA) and Its Receptor (uPAR) in Human Cerebrovascular Smooth Muscle Cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

In vitro stimulation of tissue-type plasminogen activator by Alzheimer amyloid β-peptide analogues

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Cerebrovascular smooth muscle cell surface fibrillar A beta. Alteration of the proteolytic environment in the cerebral vessel wall

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Animal models of cerebral beta-amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Analysis of cerebral amyloid angiopathy in a transgenic mouse model of Alzheimer disease using in vivo multiphoton microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Mechanisms of cerebrovascular amyloid deposition. Lessons from mouse models

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Compromised hemodynamic response in amyloid precursor protein transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Giant cell arteritis in association with cerebral amyloid angiopathy: immunohistochemical and molecular studies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Primary angiitis of the central nervous system associated with cerebral amyloid angiopathy: report of two cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Protective role of tuftsin fragment 1-3 in an animal model of intracerebral hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Intravenous NPA for the treatment of infarcting myocardium early; InTIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction. Participants in the National Registry of Myocardial Infarction 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900825-7

7 January 2021

10.1016/S1474-4422(04)00825-7

Identifiers

DOI

1 reference

10 August 2017

1 reference